Diederik Dippel received a PhD training in clinical epidemiology and decision sciences and after that, in neurology, at the Erasmus Medical Center in Rotterdam, The Netherlands. He is now a senior consultant in neurology at the Department of Neurology of Erasmus Medical Center.
His main interest is in neurovascular diseases and in acute neurology.
He participates in projects concerning the evaluation of the effect of guidelines on the quality of acute stroke care and secondary prevention after a TIA or stroke, the development and evaluation of clinical tools for prognostic diagnostic decision making in stroke and post-stroke dementia.
He has previously been the principal investigator of PAIS, a Dutch multicenter randomized clinical trial of paracetamol or placebo in acute ischemic stroke, and of PRACTISE, a cluster-randomized trial aimed at resolving barriers to the delivery of thrombolysis in acute ischemic stroke.
Currently, Dr. Dippel is on the Trial Executive Committee for MR CLEAN, a mutli-center randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands.